Atara Biotherapeutics (NASDAQ:ATRA) reported its Q4 earnings results on Thursday, March 28, 2024 at 08:30 AM.
Here’s what investors need to know about the announcement.
Earnings
Atara Biotherapeutics missed estimated earnings by -17.0%, reporting an EPS of $-0.56 versus an estimate of $-0.48.
Revenue was up $4.03 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.0 which was followed by a 6.0% drop in the share price the next day.
Here’s a look at Atara Biotherapeutics’s past performance:
| Quarter | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|
| EPS Estimate | -0.66 | -0.67 | -0.39 |
| EPS Actual | -0.66 | -0.68 | -0.72 |
| Revenue Estimate | 4.76M | 3.77M | 30.68M |
| Revenue Actual | 2.14M | 957K | 1.23M |
To track all earnings releases for Atara Biotherapeutics visit their earnings calendar here.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
